Celularity (CELUW) Shares Outstanding (Weighted Average) (2018 - 2025)

Celularity (CELUW) has 8 years of Shares Outstanding (Weighted Average) data on file, last reported at $25.6 million in Q4 2025.

• Shares Outstanding (Weighted Average) for Q4 2025 came in at $25.6 million, up 16.94% year-over-year; the trailing twelve-month figure through Dec 2025 was $25.6 million (up 16.94% YoY), and the FY2025 annual result was $25.6 million, up 16.94% from the prior year.
• Shares Outstanding (Weighted Average) eased to $25.6 million in Q4 2025 per CELUW's latest filing, from $26.3 million in the prior quarter.
• Over five years, Shares Outstanding (Weighted Average) peaked at $173.5 million in Q3 2023 and troughed at $10.1 million in Q1 2025.
• A 5-year average of $59.9 million and a median of $24.8 million in 2025 frame the typical range for Shares Outstanding (Weighted Average).
• The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Weighted Average) surged 532.77% in 2022, then plunged 93.43% in 2024.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $67.1 million in 2021, then sank by 79.14% to $14.0 million in 2022, then increased by 27.32% to $17.8 million in 2023, then grew by 22.89% to $21.9 million in 2024, then increased by 16.94% to $25.6 million in 2025.
• Business Quant data shows CELUW's Shares Outstanding (Weighted Average) at $25.6 million in Q4 2025, $26.3 million in Q3 2025, and $24.0 million in Q2 2025.